PO-091: TPExtreme randomized trial: Docetaxel-Platinum(P)-Cetuximab(C) versus 5FU-P-C in recurrent/metastatic HNSCC.
Saved in:
| Title: | PO-091: TPExtreme randomized trial: Docetaxel-Platinum(P)-Cetuximab(C) versus 5FU-P-C in recurrent/metastatic HNSCC. |
|---|---|
| Authors: | Guigay, J., Keilholz, U., Mesia, R., Vintonenko, N., Bourhis, J., Auperin, A. |
| Source: | Radiotherapy & Oncology. Feb2015 Supplement 1, Vol. 114, p46-46. 1p. |
| Subjects: | Head & neck cancer treatment, Docetaxel, Clinical trials, Physiological effects of platinum, Cetuximab, Squamous cell carcinoma, Cancer relapse |
| Database: | Engineering Source |
| ISSN: | 01678140 |
|---|---|
| DOI: | 10.1016/S0167-8140(15)34851-9 |
